Ind Swift Stock Price Today (NSE: INDSWFTLTD)
Fundamental Score
Ind Swift Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Ind Swift share price today is ₹15.76, up +0.00% on NSE/BSE as of 30 March 2026. Ind Swift (INDSWFTLTD) is a Small-cap company in the Pharmaceuticals & Biotechnology sector with a market capitalisation of ₹92.30 (Cr). The 52-week high for INDSWFTLTD share price is ₹19.90 and the 52-week low is ₹12.00. At a P/E ratio of 11.80x, INDSWFTLTD is currently trading below its industry average P/E of 33.56x.
Ind Swift Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Ind Swift Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Stability Analysis: Evaluating Ind Swift Share Price
The pharmaceuticals and biotechnology sector is currently witnessing increased pricing pressures, impacting profitability for many players. This analysis examines the financial stability of Ind Swift, with specific attention to its current market position. The current **Ind Swift share price** is ₹15.71, with a Price-to-Earnings (PE) ratio of 11.8 and a Return on Capital Employed (ROCE) of 11.86%. This report forms part of a larger 80-parameter fundamental audit personally verified by Sweta Mishra. This is for informational purposes only, not investment advice.
A crucial element in assessing any company's long-term prospects is its profitability and capital efficiency. Ind Swift's ROCE of 11.86% suggests that for every ₹100 invested in the business, the company generates approximately ₹11.86 in earnings before interest and taxes. While a higher ROCE is generally preferable, the current figure should be considered in relation to industry benchmarks and the company's historical performance. A consistent ROCE above the cost of capital contributes positively to creating a durable economic moat, attracting investor attention.
When analyzing Ind Swift, it’s helpful to consider its performance relative to its peers. While a comprehensive peer analysis requires more data, we can look at companies such as
Fabino Enterprises Ltd. A key differentiating factor is management quality, and this can often be observed through factors such as strategic capital allocation decisions, innovation initiatives, and responsiveness to evolving market dynamics. Further analysis is needed to compare both companies against these qualitative metrics.The PE ratio of 11.8 implies that investors are currently willing to pay ₹11.8 for every ₹1 of Ind Swift's earnings. Whether this valuation is justified depends on several factors, including the company's growth prospects, risk profile, and the prevailing market sentiment. It's imperative to understand that the figures presented are snapshots in time and subject to change based on market conditions and company performance. Therefore, it is important to monitor the above-mentioned financial indicators continuously to form a complete financial view. This analysis is purely observational and does not constitute a recommendation to buy or sell securities.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Ind Swift Fundamental Analysis & Valuation Benchmarking
Educational evaluation of INDSWFTLTD across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Attractive Valuation (P/E: 11.80 vs Industry: 33.56)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Excellent EPS Growth (18.19% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (18.19% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Cash Generation (₹97.74 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (55.58%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Profit Decline Concern (-131.15%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Interest Coverage (1.20x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Ind Swift Financial Statements
Comprehensive financial data for Ind Swift including income statement, balance sheet and cash flow
About INDSWFTLTD (Ind Swift)
Ind Swift is a dynamic and multifaceted pharmaceutical and biotechnology company operating at the forefront of healthcare innovation. With a steadfast commitment to improving globa...l health outcomes, Ind Swift engages in the comprehensive development, manufacturing, and marketing of a diverse portfolio of pharmaceutical products. The company's core strength lies in its ability to seamlessly integrate cutting-edge research and development with advanced manufacturing capabilities, allowing it to deliver high-quality, accessible medicines to patients worldwide. Ind Swift's unwavering dedication to excellence, coupled with its strong ethical values, has solidified its position as a trusted partner in the healthcare industry. The company's robust product line encompasses a wide spectrum of therapeutic areas, addressing critical healthcare needs across various medical specialties. Ind Swift meticulously formulates and produces a range of pharmaceutical solutions, including finished dosage forms, active pharmaceutical ingredients (APIs), and specialized herbal remedies. This comprehensive approach allows the company to cater to a diverse range of patient populations and medical conditions. Ind Swift's commitment to innovation is reflected in its continuous pursuit of novel drug delivery systems and therapeutic advancements, aimed at enhancing treatment efficacy and improving patient compliance. The therapeutic products span from areas like pain management to women's health. Ind Swift's unwavering focus on quality and regulatory compliance underscores its commitment to patient safety and product integrity. The company adheres to stringent international standards in all aspects of its operations, from research and development to manufacturing and distribution. Through rigorous quality control measures and continuous improvement initiatives, Ind Swift ensures that its products meet the highest standards of efficacy, safety, and purity. This unwavering dedication to quality has earned the company the trust of healthcare professionals and patients alike, solidifying its reputation as a reliable provider of pharmaceutical solutions.
Company Details
Key Leadership
INDSWFTLTD Share Price: Frequently Asked Questions
What is the current share price of Ind Swift (INDSWFTLTD)?
As of 30 Mar 2026, 11:00 am IST, Ind Swift share price is ₹15.76. The INDSWFTLTD stock has a market capitalisation of ₹92.30 (Cr) on NSE/BSE.
Is INDSWFTLTD share price Overvalued or Undervalued?
INDSWFTLTD share price is currently trading at a P/E ratio of 11.80x, compared to the industry average of 33.56x. Based on this relative valuation, the Ind Swift stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of INDSWFTLTD share price?
The 52-week high of INDSWFTLTD share price is ₹19.90 and the 52-week low is ₹12.00. These values are updated daily from NSE/BSE price data.
What factors affect the Ind Swift share price?
Key factors influencing INDSWFTLTD share price include quarterly earnings growth (Sales Growth: 7.15%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Ind Swift a good stock for long-term investment?
Ind Swift shows a 5-year Profit Growth of 18.19% and an ROE of N/A%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of N/A before investing in INDSWFTLTD shares.
How does Ind Swift compare with its industry peers?
Ind Swift competes with major peers in the Pharmaceuticals & Biotechnology. Investors should compare INDSWFTLTD share price P/E of 11.80x and ROE of N/A% against the industry averages to determine competitive standing.
What is the P/E ratio of INDSWFTLTD and what does it mean?
INDSWFTLTD share price has a P/E ratio of 11.80x compared to the industry average of 33.56x. Investors pay ₹12 for every ₹1 of annual earnings.
How is INDSWFTLTD performing according to Bull Run's analysis?
INDSWFTLTD has a Bull Run fundamental score of 45.8/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does INDSWFTLTD belong to?
INDSWFTLTD operates in the Pharmaceuticals & Biotechnology industry. This classification helps understand the competitive landscape and sector-specific trends affecting Ind Swift share price.
What is Return on Equity (ROE) and why is it important for INDSWFTLTD?
INDSWFTLTD has an ROE of N/A%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Ind Swift generates profits from shareholders capital.
How is INDSWFTLTD debt-to-equity ratio and what does it indicate?
INDSWFTLTD has a debt-to-equity ratio of N/A, which indicates conservative financing with low financial risk.
What is INDSWFTLTD dividend yield and is it a good dividend stock?
INDSWFTLTD offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Ind Swift shares.
How has INDSWFTLTD share price grown over the past 5 years?
INDSWFTLTD has achieved 5-year growth rates of: Sales Growth 9.35%, Profit Growth 18.19%, and EPS Growth 18.19%.
What is the promoter holding in INDSWFTLTD and why does it matter?
Promoters hold 55.58% of INDSWFTLTD shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Ind Swift.
What is INDSWFTLTD market capitalisation category?
INDSWFTLTD has a market capitalisation of ₹92 crores, placing it in the Small-cap category.
How volatile is INDSWFTLTD stock?
INDSWFTLTD has a beta of N/A. A beta > 1 suggests the Ind Swift stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is INDSWFTLTD operating profit margin trend?
INDSWFTLTD has a 5-year average Operating Profit Margin (OPM) of 9.43%, indicating the company's operational efficiency.
How is INDSWFTLTD quarterly performance?
Recent quarterly performance shows Ind Swift YoY Sales Growth of 7.15% and YoY Profit Growth of -131.15%.
What is the institutional holding pattern in INDSWFTLTD?
INDSWFTLTD has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Ind Swift stock.